Loading data
PGNYNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.29 bn USD | 1.17 bn USD | 1.09 bn USD | 786.91 m USD | 500.62 m USD |
| Cost of revenue | 984.18 m USD | 913.86 m USD | 849.8 m USD | 619.59 m USD | 388.49 m USD |
| Gross profit | 304.48 m USD | 253.36 m USD | 238.8 m USD | 167.33 m USD | 112.14 m USD |
| Research and development expense | 9.5 m USD | — | — | — | — |
| Operating profit | 85.28 m USD | 67.46 m USD | 62.18 m USD | 23.34 m USD | 32.34 m USD |
| Profit before tax | 95.43 m USD | 83.2 m USD | 70.69 m USD | 24.44 m USD | 32.44 m USD |
| Income tax expense | 36.91 m USD | 28.87 m USD | 8.65 m USD | -5.92 m USD | -33.3 m USD |
| Net income (reported basis) | 58.52 m USD | 54.34 m USD | 62.04 m USD | 30.36 m USD | 65.77 m USD |
| Net income attributable to common shareholders | 58.52 m USD | 54.34 m USD | 62.04 m USD | 30.36 m USD | 65.77 m USD |
| Basic earnings per share | 0.68 USD/share | 0.59 USD/share | 0.65 USD/share | 0.33 USD/share | 0.74 USD/share |
| Diluted earnings per share | 0.65 USD/share | 0.57 USD/share | 0.62 USD/share | 0.3 USD/share | 0.66 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.